Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2021 Financial Results on February 8, 2022

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) will announce its fourth quarter and 2021 annual financial results on February 8 after market close. A conference call will follow at 5:00 p.m. Eastern Time to discuss these results and recent developments. Inspire focuses on innovative solutions for patients with obstructive sleep apnea, offering the first FDA-approved neurostimulation therapy for moderate to severe cases. For more details, visit inspiresleep.com.

Positive

• First FDA-approved neurostimulation technology for obstructive sleep apnea.

Negative

• None.

MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial results for the fourth quarter and year ended December 31, 2021 after the close of trading on Tuesday, February 8.   Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

Tuesday, February 8th @ 5:00 p.m. Eastern Time:
Domestic:	(800) 344-0786
International:	(209) 905-5969
Conference ID:	6196895
Webcast:	https://edge.media-server.com/mmc/p/yqez27hd

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
inspire@lifesciadvisors.com
646-597-6989

FAQ

When will Inspire Medical Systems announce its fourth quarter results?

Inspire Medical Systems will announce its fourth quarter results on February 8, 2022.

What time is the conference call for Inspire Medical Systems?

The conference call will take place at 5:00 p.m. Eastern Time on February 8, 2022.

How can I access the Inspire Medical Systems conference call?

The conference call can be accessed domestically at (800) 344-0786 and internationally at (209) 905-5969.

What is Inspire Medical Systems known for?

Inspire Medical Systems is known for its innovative solutions for obstructive sleep apnea, including the first FDA-approved neurostimulation technology.

Where can I find more information about Inspire Medical Systems?

More information about Inspire Medical Systems can be found at their website, www.inspiresleep.com.